(Q24240928)

1

0 references

Martin Aigner

2

0 references

Michael Ossege

3

0 references

Elisabeth Pernicka

4

0 references

Thomas Sycha

Cochrane Database of Systematic Reviews

6

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

Tiapride versus glafenine: a double-blind comparative study in the management of acute rheumatic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Haloperidol as an adjunct analgesic in the management of postoperative pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Pimozide therapy for trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Fluphenazine for Tension Headache; Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Avoiding psychic adverse effects during induction of neurolept anaesthesia with levomepromazine. A double-blind study of levomepromazine and droperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Prophylactic antiemetics for laparoscopic cholecystectomy: a comparison of perphenazine, droperidol plus ondansetron, and droperidol plus metoclopramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Droperidol vs prochlorperazine for the treatment of acute headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Psychotropic adjuvant analgesics for pain in cancer and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Comparison of fentanyl and droperidol mixture (neuroleptanalgesia II) with morphine on clinical outcomes in unstable angina patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Olanzapine in the management of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Olanzapine for the treatment of fibromyalgia symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Pharmacological approaches other than opioids in chronic non-cancer pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

The neuroleptics as adjuvant analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Antinociceptive mechanism of L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Olanzapine in the treatment of refractory migraine and chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

Repetitive Intravenous Prochlorperazine Treatment of Patients With Refractory Chronic Daily Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

[Chronic facial pain from psychiatric point of view - differential diagnosis and therapeutic strategies]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

The Atypical Neuroleptics Clozapine and Olanzapine Differ Regarding Their Antinociceptive Mechanisms and Potency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

Clinical effectiveness of antidepressants and antipsychotics in chronic benign pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB2

7 January 2021